Gilder Gagnon Howe & CO LLC Avidity Biosciences, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $135,246 - $304,641	13,444 New	13,444 $298,000
Q1 2022 May 16, 2022	SELL	$14.2 - $23.78 $439,958 - $736,775	-30,983 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$20.4 - $28.66 $2,570 - $3,611	-126 Reduced 0.41%	30,983 $736,000
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $300,348 - $416,948	16,539 Added 113.51%	31,109 $766,000
Q2 2021 Aug 16, 2021	BUY	$19.62 - $29.26 $27,742 - $41,373	1,414 Added 10.75%	14,570 $360,000
Q1 2021 May 17, 2021	BUY	$20.28 - $28.15 $68,161 - $94,612	3,361 Added 34.31%	13,156 $287,000
Q4 2020 Feb 16, 2021	SELL	$24.73 - $35.12 $816 - $1,158	-33 Reduced 0.34%	9,795 $250,000
Q3 2020 Nov 16, 2020	SELL	$23.35 - $35.94 $4,016 - $6,181	-172 Reduced 1.72%	9,828 $277,000
Q2 2020 Aug 14, 2020	BUY	$26.62 - $31.5 $266,200 - $315,000	10,000 New	10,000 $283,000

252

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.67B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.